VINIA Achieves #1 US Resveratrol Brand Status, Drives Over $30M in 2025 Revenue for BioHarvest Sciences
Summary
BioHarvest Sciences announced that its VINIA product has achieved the #1 position as the Resveratrol Polyphenol Nutraceutical Brand in the United States, based on 2025 annual sales. This significant market leadership is supported by VINIA generating over $30 million in U.S. revenue for full-year 2025 and approximately $85 million in global cumulative revenue to date. For a company with a market capitalization of under $100 million, these revenue figures represent a substantial portion of its business and validate the success of its proprietary Botanical Synthesis platform technology. This news is a strong positive catalyst, indicating robust product adoption and financial performance, which could significantly impact investor sentiment and the stock price. Investors will watch for continued growth in VINIA sales and further expansion of the Botanical Synthesis platform.
At the time of this announcement, BHST was trading at $4.36 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $98.8M. The 52-week trading range was $4.10 to $12.80. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: TMX Newsfile.